The Efficacy and Safety of Hypofractionated Radiation Therapy With Tomotherapy for Advanced or Recurrent Hepatocellular Carcinoma

The effects of radiotherapy on hepatocellular carcinoma (HCC) still remain to be further proved. The dose of radiotherapy is generally 2Gy*25f. In the current study, we prospectively investigated the clinical outcomes of advanced or recurrent HCC patients who received hypofractionated radiotherapy a...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Jie, Yan, Jing, Zhu, Sihui, Kong, Weiwei, Zou, Zhengyun, Liu, Juan, Li, Shuangshuang, Liu, Baorui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201615/
https://www.ncbi.nlm.nih.gov/pubmed/34136374
http://dx.doi.org/10.3389/fonc.2021.559112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201615/
https://www.ncbi.nlm.nih.gov/pubmed/34136374
http://dx.doi.org/10.3389/fonc.2021.559112

Ejemplares similares